You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 248 No. 4, July 23, 1982 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Use of Radionuclide Bone Imaging in a University Medical Center

Stephan D. Fihn, MD, MPH; Eric B. Larson, MD, MPH; Thomas R. Rudd, MD; Wil B. Nelp, MD

JAMA. 1982;248(4):439-442.


Abstract

To assess the diagnostic utility of radionuclide bone imaging, we reviewed all examinations performed during a two-year period in a university medical center. The indication(s) for each bone image and its interpretation were compared by reviewing requisition forms and medical records. Thirty-nine percent of 988 studies demonstrated relevant abnormalities. Yields of pertinent positive findings were greatest in patients with cancers of the breast (40%) and prostate (38%) and lowest in women with uterine cancer (15%), patients with previously normal bone images, and individuals with suspected but unconfirmed malignancy. Incidental findings, unrelated to the indication for imaging, occurred frequently (up to 41% of cases). We did not find a sizable number of negative studies that could readily be labeled as unnecessary, suggesting that bone imaging is generally a useful procedure as applied by physicians in this setting.

(JAMA 1982;248:439-442)



Author Affiliations

From the Departments of Medicine (Drs Fihn, Larson, and Nelp) and Nuclear Medicine (Drs Rudd and Nelp), University of Washington, Seattle. Dr Fihn was a Public Health Service Fellow in the University of Washington, Robert Wood Johnson Clinical Scholars Program. Dr Larson is a Henry J. Kaiser Family Foundation Faculty Scholar in General Internal Medicine.


Footnotes

The opinions expressed herein reflect those of the authors and are not necessarily those of the Robert Wood Johnson Foundation, the Public Health Service, or the Kaiser Foundation.

Reprint requests to Department of Medicine, RG-20, University of Washington, Seattle, WA 98195 (Dr Larson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.